Climb Bio (CLYM) Payables (2020 - 2026)
Climb Bio (CLYM) reported Payables of $860000.0 for Q1 2026, up 10.68% on a YoY basis from $777000.0 in Q1 2025, and down 62.1% quarter-over-quarter from $2.3 million in Q4 2025.
Climb Bio (CLYM) Payables (2020 - 2026) Analysis & Trends
Climb Bio has reported Payables for 7 years, with the latest figure at $860000.0 in Q1 2026.
- For the quarter ending Q1 2026, Payables rose 10.68% year-over-year to $860000.0; the trailing twelve-month figure through Mar 2026 stood at $860000.0 (up 10.68% YoY), and the FY2025 full-year result was $2.3 million, up 221.84% from the prior year.
- Payables for Q1 2026 stood at $860000.0, down from $2.3 million in the prior quarter.
- The five-year high for Payables was $2.3 million in Q4 2025, with the low at $21000.0 in Q2 2022.
- Historically, Payables has averaged $739705.9 across 5 years, with a median of $750000.0 in 2022.
- The largest YoY upside for Payables was 4080.95% in 2023 against a maximum downside of 91.2% in 2023.
- Climb Bio's Payables stood at $750000.0 in 2022, then slumped by 91.2% to $66000.0 in 2023, then surged by 968.18% to $705000.0 in 2024, then jumped by 221.84% to $2.3 million in 2025, then sank by 62.1% to $860000.0 in 2026.
- The last three Payables figures came in at $860000.0 (Q1 2026), $2.3 million (Q4 2025), and $477000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 34.55 Mn |
| 10 | Climb Bio | 740.73 Mn | 740.73 Mn | - | 860,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 860,000.00 |
| Dec 31, 2025 | 2.27 Mn |
| Sep 30, 2025 | 477,000.00 |
| Jun 30, 2025 | 946,000.00 |
| Mar 31, 2025 | 777,000.00 |
| Dec 31, 2024 | 705,000.00 |
| Sep 30, 2024 | 291,000.00 |
| Jun 30, 2024 | 509,000.00 |
| Mar 31, 2024 | 85,000.00 |
| Dec 31, 2023 | 66,000.00 |
| Sep 30, 2023 | 736,000.00 |
| Jun 30, 2023 | 878,000.00 |
| Mar 31, 2023 | 864,000.00 |
| Dec 31, 2022 | 750,000.00 |
| Sep 30, 2022 | 1.49 Mn |
| Jun 30, 2022 | 21,000.00 |
| Mar 31, 2022 | 847,000.00 |
| Dec 31, 2021 | 1.40 Mn |
| Sep 30, 2021 | 2.58 Mn |
| Jun 30, 2021 | 127,000.00 |